Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON ALPHA

NCT00002847 is registered in ClinicalTrials.gov with Blumenthal Cancer Center at Carolinas Medical Center as lead sponsor.

NCT NCT00002847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TREATMENT OF METASTATIC RENAL CELL CARCINOMA WITH SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 AND INTERFERON ALPHA
Lead sponsor
Blumenthal Cancer Center at Carolinas Medical Center
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 1995
Completion date
Not reported
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer